Literature DB >> 33762720

The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.

Allan M Golder1, Donald C McMillan2, James H Park2, David Mansouri2, Paul G Horgan2, Campbell S Roxburgh2.   

Abstract

BACKGROUND: The pre-operative systemic inflammatory response (SIR) measured using an acute-phase-protein-based score (modified Glasgow Prognostic Score (mGPS)) or the differential white cell count (neutrophil-lymphocyte ratio (NLR)) demonstrates prognostic significance following curative resection of colon cancer. We investigate the complementary use of both measures to better stratify outcomes.
METHODS: The effect on survival of mGPS and NLR was examined using uni/multivariate analysis (UVA/MVA) in patients undergoing curative surgery for colon cancer. The synergistic effect of these scores in predicting OS/CSS was examined using a Systemic Inflammatory Grade (SIG).
RESULTS: One thousand seven hundred and eight patients with TNM-I-III colon cancer were included. On MVA both mGPS and NLR were significant for OS (HR 1.16/1.21, respectively). Three-year survival stratified by mGPS was 83-58%(TNM-I-III), 87-65%(TNM-II) and 75-49%(TNM-III), and by NLR was 84-62%(TNM-I-III), 88-69%(TNM-II) and 77-49%(TNM-III). When mGPS and NLR were combined to form an overall SIG 0/1/2/3/4, this stratified 3-year OS 88%/84%/76%/65%/60% and CSS 93%/90%/82%/73%/70%, respectively (both p < 0.001). SIG stratified OS 93-68%/82-48% and CSS 97-80%/86-58% in TNM Stage II/III disease, respectively (all p < 0.001).
CONCLUSIONS: The present study shows that the pre-operative SIR in patients undergoing curative surgery for colon cancer is best measured using a SIG utilising mGPS and NLR.

Entities:  

Mesh:

Year:  2021        PMID: 33762720      PMCID: PMC8144393          DOI: 10.1038/s41416-021-01308-x

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  3 in total

1.  Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?

Authors:  Xuefeng Li; Lesheng Teng; Zhaogang Yang
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

2.  Relationship between pre-operative glycated haemoglobin and surgical site infection in patients undergoing elective colon cancer surgery.

Authors:  Chee Mei Cheong; Allan M Golder; Paul G Horgan; Campbell S D Roxburgh; Donald C McMillan
Journal:  Oncol Lett       Date:  2022-07-05       Impact factor: 3.111

3.  Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma.

Authors:  Uiju Cho; Yeoun-Eun Sung; Min-Sik Kim; Youn-Soo Lee
Journal:  Biomedicines       Date:  2022-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.